- Home
- CSTE vs COEP Comparison
CSTE vs COEP Comparison
Compare CSTE & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSTE | COEP |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | Israel | United States |
| Employees | N/A | 7 |
| Industry | Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7M | 72.7M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSTE | COEP |
|---|---|---|
| Price | $0.74 | $12.48 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 319.6K | 30.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $6.32 |
| 52 Week High | $3.26 | $21.41 |
Technical Indicators
Market Signals| Indicator | CSTE | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 19.98 | 48.81 |
| Support Level | N/A | $10.83 |
| Resistance Level | $2.00 | $13.12 |
| Average True Range (ATR) | 0.16 | 0.83 |
| MACD | -0.08 | 0.16 |
| Stochastic Oscillator | 3.60 | 52.61 |
Price Performance
Historical ComparisonAbout CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.